TrialEuropean heart journal2017

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Javier Escaned et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.